Fractionated carbon ion irradiation of skull base tumors at GSI. First clinical results and future perspectives;Bestrahlung von schadelbasistumoren mit kohlenstoffionen bei der GSI. Erste klinische ergebnisse und zukunftige perspektiven

Strahlentherapie und Onkologie

Volumn 176, Issue 5, 2000, Pages 211-216

  Debus, Jürgen ^a,e   Haberer, Thomas ^b   Schulz Ertner, Daniela ^a   Jäkel, Oliver ^c   Wenz, Frederik ^a   Enghardt, Wolfgang ^d   Schlegel, Wolfgang ^c   Kraft, Gerhard ^b   Wannenmacher, Michael ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GSI HELMHOLTZZENTRUM FÜR SCHWERIONENFORSCHUNG GMBH   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d Forschungszentrum Rossendorf bei Dresden   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Carbon ion; GSI; Heavy ion therapy; Radiotherapy; Skull base

Indexed keywords

CARBON; HEAVY ION;

ADULT; ARTICLE; BRAIN RADIATION; CANCER CONTROL; CANCER RADIOTHERAPY; CHONDROSARCOMA; CHORDOMA; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; QUALITY CONTROL; SKULL BASE TUMOR; THREE DIMENSIONAL IMAGING; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; ADOLESCENT; AGED; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED RADIOTHERAPY; DISEASE FREE SURVIVAL; FOLLOW UP; HEALTH CARE QUALITY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; SCINTISCANNING; STANDARD;

ADOLESCENT; ADULT; AGED; CARBON; CHONDROSARCOMA; CHORDOMA; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HEAVY IONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; QUALITY ASSURANCE, HEALTH CARE; RADIOTHERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SKULL BASE NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034071369     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000660050002     Document Type: Article

References (19)

1. Castro JR, Linstadt DE, Bahary J-P, et al. Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys 1994;29:647-55.
2. Castro JR, Phillips TL, Prados M, et al. Neon heavy charged particle radiotherapy of glioblastoma of the brain. Int J Radiat Oncol Biol Phys 1997;38:257-61.
3. Catton C, O'Sullivan B, Bell R, et al. Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 1996;41:67-70.
4. Eickhoff H, Haberer T, Kraft G, et al. The GSI cancer therapy project. Strahlenther Onkol 1999;175:Suppl 11:21-4.
5. Enghardt W, Debus J, Haberer T, et al. The application of PET to quality assurance of heavy-ion tumor therapy. Strahlenther Onkol 1999;175:Suppl 11:33-6.
6. Gademann G, Schlegel W, Bürkelbach J, et al. Dreidimensionale Bestrahlungsplanung - Untersuchungen zur klinischen Integration. Strahlenther Onkol 1993;169:159-67.
7. Gademann G, Wannenmacher M. Charged particle therapy to pediatric tumors of the retroperitoneal region: a possible indication. Int J Radiat Oncol Biol Phys 1991;22:375-81.
8. Gay EL, Sekhar LN, Rubinstein E, et al. Chordomas and chondrosarcomas of the cranial base: Results and follow-up of 60 patients. Neurosurgery 1995;36:887-97.
9. Haberer T, Becher W, Schardt D, et al. Magnetic scanning system for heavy ion therapy. Nucl Instr and Meth in Phys Res 1993;330:296-305.
10. Hartmann GH, Bauer Kirpes B, Serago CE, et al. Precision and accuracy of stereotactic convergent beam irradiations from a linear accelerator. Int J Radiat Oncol Biol Phys 1994;28:481-92.
11. Hug EB, Munzenrider JE. Charged particle therapy for base skull tumors: past accomplishments and future challenges. Int J Radiat Oncol Biol Phys 1994;29:911-12.
12. Jäkel O, Krämer M, Hartmann GH, et al. Treatment planning for the heavy-ion facility at GSI. Strahlenther Onkol 1999;175:Suppl II: 15-7.
13. Kanai T, Endo M, Minohara S, et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys 1999;44:201-10.
14. Kraft G. Radiotherapy with heavy ions: radiobiology, clinical indications and experiences at GSI, Darmstadt. Tumori 1998;84:200-4.
15. Kraft G. RBE and its interpretation. Strahlenther Onkol 1999;175:Suppl 11:44-7.
16. Miyamoto T, Aoyagi H, Tsujii H et al. Heavy ion radiotherapy for lung cancer. Journal of Japan Surgical Society 1997;98:60-7.
17. Scholz M, Kraft-Weyrather W, Ritter S, et al. Cell cycle delays induced by heavy ion irradiation of synchronous mammalian cells. Int J Radiat Oncol Biol Phys 1994;66:59-75.
18. Suit HD. Assessment of the impact of local control on clinical outcome. In: Meyer JL, Purdy JA, eds. 3-D Conformal Radiotherapy. Front Radiat Ther Oncol. Basel: Karger, 1996:17-23.
19. Watkins L, Khudados ES, Kaleoglu M, et al. Skull base chordomas: a review of 38 patients, 1958-1988. Br J Neurosurg 1993;7:241-8.